Melissa R Partin1, Jonathan S Slater, Lee Caplan. 1. Center for Chronic Disease Outcomes Research (152/2E), Minneapolis VA Medical Center, 1 Veterans Drive, Minneapolis, MN 55417, USA. Melissa.partin@va.gov
Abstract
BACKGROUND: As overall mammography rates approach national goals, mammography promotion efforts must increasingly focus on repeat adherence. This randomized controlled trial examined the effect of two interventions on repeat mammography utilization using various adherence definitions. METHODS:1,558 women aged 40-63 receiving a mammogram through a federally funded screening program were randomized to three groups: mailed reminder (minimum group); mailed thank you card, newsletters, and reminder (maximum group); no mailings (control). The primary outcome (repeat mammogram) was assessed 13, 15, 18, and 24 months after the qualifying mammogram using administrative data. RESULTS: The proportions receiving a repeat mammogram within 13 months were 0.28, 0.30, and 0.32 for control, minimum, and maximum groups, respectively. The corresponding proportions were 0.38, 0.43, and 0.45 at 15 months; 0.43, 0.49, and 0.51 at 18 months; and 0.47, 0.52, and 0.54 at 24 months. There were no significant differences across study groups at 13 months. The differences between control and maximum subjects at 15, 18, and 24 months were statistically significant. The differences between control and minimum subjects were significant only at 18 months. CONCLUSIONS: The two low-cost mailed interventions evaluated modestly increased repeat mammography utilization. However, effects were not visible until at least 15 months after the qualifying mammogram.
RCT Entities:
BACKGROUND: As overall mammography rates approach national goals, mammography promotion efforts must increasingly focus on repeat adherence. This randomized controlled trial examined the effect of two interventions on repeat mammography utilization using various adherence definitions. METHODS: 1,558 women aged 40-63 receiving a mammogram through a federally funded screening program were randomized to three groups: mailed reminder (minimum group); mailed thank you card, newsletters, and reminder (maximum group); no mailings (control). The primary outcome (repeat mammogram) was assessed 13, 15, 18, and 24 months after the qualifying mammogram using administrative data. RESULTS: The proportions receiving a repeat mammogram within 13 months were 0.28, 0.30, and 0.32 for control, minimum, and maximum groups, respectively. The corresponding proportions were 0.38, 0.43, and 0.45 at 15 months; 0.43, 0.49, and 0.51 at 18 months; and 0.47, 0.52, and 0.54 at 24 months. There were no significant differences across study groups at 13 months. The differences between control and maximum subjects at 15, 18, and 24 months were statistically significant. The differences between control and minimum subjects were significant only at 18 months. CONCLUSIONS: The two low-cost mailed interventions evaluated modestly increased repeat mammography utilization. However, effects were not visible until at least 15 months after the qualifying mammogram.
Authors: Jennifer M Gierisch; Jo Anne Earp; Noel T Brewer; Barbara K Rimer Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-03-30 Impact factor: 4.254
Authors: Diana S M Buist; Hongyuan Gao; Melissa L Anderson; Tracy Onega; Susan Brandzel; Melissa A Rabelhofer; Susan Carol Bradford; Erin J Aiello Bowles Journal: Prev Med Date: 2017-06-24 Impact factor: 4.018
Authors: Terry C Davis; Connie L Arnold; Charles L Bennett; Michael S Wolf; Dachao Liu; Alfred Rademaker Journal: J Womens Health (Larchmt) Date: 2015-02-18 Impact factor: 2.681
Authors: Jeanne M Ferrante; Pamela Ohman-Strickland; Karissa A Hahn; Shawna V Hudson; Eric K Shaw; Jesse C Crosson; Benjamin F Crabtree Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-11 Impact factor: 4.254
Authors: Jennifer M Gierisch; Suzanne C O'Neill; Barbara K Rimer; Jessica T DeFrank; J Michael Bowling; Celette Sugg Skinner Journal: Cancer Epidemiol Date: 2009-05-29 Impact factor: 2.984
Authors: Rebecca A Shelby; Cindy D Scipio; Tamara J Somers; Mary Scott Soo; Kevin P Weinfurt; Francis J Keefe Journal: J Clin Oncol Date: 2012-02-13 Impact factor: 44.544
Authors: Adrianne C Feldstein; Nancy Perrin; A Gabriela Rosales; Jennifer Schneider; Mary M Rix; Kara Keels; Stephanie Schoap; Russell E Glasgow Journal: Am J Prev Med Date: 2009-08 Impact factor: 5.043